A5086444618- Cardiac Imaging and Diagnostics
- Cardiac Valve Diseases and Treatments
- Cardiovascular Function and Risk Factors
- Pulmonary Hypertension Research and Treatments
- Advanced MRI Techniques and Applications
- Congenital Heart Disease Studies
- Cardiac, Anesthesia and Surgical Outcomes
- Infective Endocarditis Diagnosis and Management
- Ultrasound in Clinical Applications
- Aortic Disease and Treatment Approaches
- Aortic aneurysm repair treatments
- Nuclear Structure and Function
- Advanced X-ray and CT Imaging
- Cardiac Structural Anomalies and Repair
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- RNA Research and Splicing
- Viral Infections and Immunology Research
- Cardiac pacing and defibrillation studies
- Renal and Vascular Pathologies
- Dialysis and Renal Disease Management
- Hemodynamic Monitoring and Therapy
- Coronary Interventions and Diagnostics
- Mechanical Circulatory Support Devices
- Ultrasound and Hyperthermia Applications
University of Michigan
2013-2024
Michigan Medicine
2013-2024
VA Ann Arbor Healthcare System
2020-2022
Ann Arbor VA Medical Center
2021
American Society of Echocardiography
2019
American Heart Association
2019
American Association for Thoracic Surgery
2019
University of Chicago Medical Center
2011-2016
University of Chicago
2010-2015
University of Bologna
2015
Background: Patients with end-stage kidney disease (ESKD) on dialysis were excluded from clinical trials of direct oral anticoagulants for atrial fibrillation (AF). Recent data have raised concerns regarding the safety dabigatran and rivaroxaban, but apixaban has not been evaluated despite current labeling supporting its use in this population. The goal study was to determine patterns associated outcomes dialysis-dependent patients ESKD AF. Methods: We performed a retrospective cohort...
Background Right ventricular ( RV ) strain is a potentially useful prognostic marker in patients with pulmonary arterial hypertension PAH ). However, published reports regarding the accuracy of two‐dimensional echocardiography (2 DE )‐derived against an independent reference this patient population are limited. The aims study were: (1) to relationship between 2 longitudinal and cardiovascular magnetic resonance CMR ejection fraction RVEF ; (2) compare ‐derived these patients; (3) determine...
Placebo-controlled trials for pulmonary arterial hypertension are no longer acceptable because new therapies must show clinically significant effects on top of standard treatment. The purpose this study was to estimate sample sizes and imaging costs the planning a hypothetical drug trial using detect changes in right ventricular size function response combined therapy.Same-day cardiovascular MR (CMR) 2-dimensional (2D) 3D transthoracic echocardiography (2DTTE 3DTTE) were performed 22...
Adenosine cardiovascular magnetic resonance (CMR) can accurately quantify myocardial perfusion reserve. While regadenoson is increasingly employed due to ease of use, imaging protocols have not been standardized. We sought determine the optimal CMR protocol for quantifying reserve index (MPRi) – more specifically, whether stress should be performed before or after rest imaging. Twenty healthy subjects underwent during resting conditions, regadenoson-induced hyperemia (0.4 mg), and 15 min...